Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
26.60 BRL | +1.99% | +1.88% | -10.07% |
Sales 2023 * | 47.86 B 9,727 M | Sales 2024 * | 53.10 B 10.79 B | Capitalization | 58.80 B 11.95 B |
---|---|---|---|---|---|
Net income 2023 * | 1,933 M 393 M | Net income 2024 * | 3,111 M 632 M | EV / Sales 2023 * | 1,38x |
Net Debt 2023 * | 7,309 M 1,485 M | Net Debt 2024 * | 7,835 M 1,592 M | EV / Sales 2024 * | 1,25x |
P/E ratio 2023 * | 31,5x | P/E ratio 2024 * | 20,2x | Employees | - |
Yield 2023 * | 0,68% | Yield 2024 * | 1,17% | Free-Float | 35.25% |
More Fundamentals
* Assessed data
More news
1 day | +1.99% | ||
1 week | +2.86% | ||
Current month | +23.03% | ||
1 month | +20.09% | ||
3 months | -10.01% | ||
6 months | -9.68% | ||
Current year | -10.07% |
1 week
25.59
26.97

1 month
21.39
26.97

Current year
19.35
37.57

1 year
19.35
37.57

3 years
19.35
77.30

5 years
19.35
77.30

10 years
19.35
77.30

Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 42 | - | |
Director of Finance/CFO | 54 | 2015 | |
Director/Board Member | 47 | 1997 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | - | |
Director/Board Member | 47 | 1997 | |
Director/Board Member | 53 | 2015 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.13% | 2 M€ | -14.14% | ||
1.40% | 13 M€ | +23.36% |
Date | Price | Change | Volume |
---|---|---|---|
23-11-30 | 26.60 | +1.99% | 6,157,900 |
23-11-29 | 26.08 | -1.73% | 5,305,600 |
23-11-28 | 26.54 | +1.03% | 4,211,100 |
23-11-27 | 26.27 | +1.94% | 3,470,600 |
23-11-24 | 25.77 | -1.30% | 4,122,900 |
Delayed Quote Bolsa de Valores de Sao Paulo, November 30, 2023 at 04:07 pm EST
More quotes
Rede D'Or São Luiz S.A. specializes in health care and diagnostic services. The company offers medical hospital services and surgical interventions in the fields of oncology, gynecology, cardiology, dietetics, orthopedics and dermatology.
At the end of 2021, Rede D'Or São Luiz S.A. operated a network of 64 hospitals (10,618 beds) as well as medical analysis and imaging laboratories.
Calendar
2024-03-25
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
B-
Sell
Buy

Mean consensus
BUY
Number of Analysts
10
Last Close Price
26.50BRL
Average target price
35.36BRL
Spread / Average Target
+33.45%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.07% | 12 010 M $ | |
-27.08% | 86 093 M $ | |
+4.38% | 66 669 M $ | |
+27.83% | 25 750 M $ | |
-7.89% | 18 176 M $ | |
-12.28% | 15 209 M $ | |
+23.09% | 11 997 M $ | |
-20.43% | 11 171 M $ | |
-2.42% | 9 266 M $ | |
+35.88% | 9 099 M $ |